Funding
Funding not disclosed
Founders
Product
Problem
The development of effective cancer treatments is hindered by inefficient drug discovery and development processes, limiting patient access to advanced medications. Traditional methods often lack the speed and innovation needed to address the evolving challenges in immuno-oncology.
Solution
SCBIO is a therapeutics company focused on immuno-oncology, utilizing proprietary platform technologies to accelerate the development of novel cancer treatments. The company streamlines the drug discovery and development process to enhance patient access to effective medications. SCBIO focuses on developing original technologies and securing a diverse pipeline of drug candidates.
Target Audience
SCBIO's primary customers are patients in need of advanced cancer treatments, as well as healthcare providers and researchers in the field of immuno-oncology.
Features
- Focus on novel therapeutics in immuno-oncology
- Proprietary platform technologies for drug discovery
- Streamlined drug development processes
- Diverse pipeline of drug candidates (SC0001, SC0002, SC0003, SC0004, SC0005)